This study compared two types of radiation treatment for prostate cancer that have not spread. One treatment, called SBRT, gives higher doses of radiation in fewer visits. The other, called IMRT, spreads the treatment out over more visits. Researchers wanted to know if SBRT could cause fewer side effects and still work just as well. They found that men who got SBRT had fewer bowel and bladder problems, so they felt better during treatment. But IMRT may have done a slightly better job of keeping the cancer under control over time.
This means physicians and patients have a choice to make. If comfort and fewer side effects matter most, SBRT may be the better fit. If the goal is long-term cancer control, IMRT may be a stronger choice. The findings highlight the importance of shared decision-making, with clinicians helping patients weigh quality-of-life considerations against disease control outcomes when selecting a treatment approach.
By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.
Are you a healthcare professional? Register with us today!
